Medifast Inc
MED· NYSE
Filed Mar 16, 2018 · 10-K · 75 days after period end · 0001144204-18-015288
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | $78.01M | $62.47M | $61.31M | $62.30M |
| Net Income | $7.31M | $4.11M | $3.86M | -$3.36M |
| EPS Diluted | $0.60 | $0.34 | $0.33 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 16, 2018 · 75 d after period end